Blimp-1 may be a pivotal target for the modulation of the balance between pro- and anti-inflammatory responses, thereby dampening the chronic inflammation that characterizes diseases such as rheumatoid arthritis, inflammatory bowel disease, and asthma. The gene discussed is PRDM1; the disease is inflammatory bowel disease.